February 14, 2014 Agila Specialties Private Limited Initiates Voluntary Nationwide Recall of 10 Lots of Etomidate Injection 2 mg mL - 10 mL and 20 mL due to the Presence of Particulate Matter and or Illegible and Missin - MedWatch - Document - PDFSEARCH.IO

First Page	Meta Content
	February 14, 2014 Agila Specialties Private Limited Initiates Voluntary Nationwide Recall of 10 Lots of Etomidate Injection 2 mg/mL - 10 mL and 20 mL due to the Presence of Particulate Matter and/or Illegible and Missin Add to Reading List Open Document File Size: 10,30 KB Share Result on Facebook City PITTSBURGH / Warsaw / / Company Agila Specialties Polska / Pfizer / Agila Specialties Private Limited / Initiates Voluntary Nationwide / Mylan Inc. / / Country Poland / / Event Product Recall / Product Issues / / / IndustryTerm generic pharmaceuticals / drug product / pharmaceutical access / active pharmaceutical ingredient manufacturers / healthcare / pharmaceutical / report Online / / MedicalCondition phlebitis / embolism / HIV/AIDS / infection / / MedicalTreatment antiretroviral therapies / / Organization U.S. Food and Drug Administration / Intravenous administration / FDA / / / Position physician / / Product Agila Specialties Private Limited Initiates Voluntary Nationwide / Etomidate / This / / URL www.fda.gov/medwatch/report.htm / www.fda.gov/MedWatch/getforms.htm / / SocialTag Pharmaceutical sciences Etomidate Medicine Clinical research Mylan MedWatch Food and Drug Administration Imidazoles General anesthetics Janssen Pharmaceutica

February 14, 2014 Agila Specialties Private Limited Initiates Voluntary Nationwide Recall of 10 Lots of Etomidate Injection 2 mg/mL - 10 mL and 20 mL due to the Presence of Particulate Matter and/or Illegible and MissinAdd to Reading List